|
市場調査レポート
商品コード
1346848
MRI造影剤の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測Global MRI Contrast Media Agents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
||||||
カスタマイズ可能
|
|||||||
| MRI造影剤の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測 |
|
出版日: 2023年08月01日
発行: Value Market Research
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
|
- 全表示
- 概要
- 図表
- 目次
MRI造影剤市場の世界需要は、2022年の29億8,000万米ドルから2030年には55億8,000万米ドル近くの市場規模に達すると推定され、調査期間2023～2030年のCAGRは8.15%です。
MRI（磁気共鳴画像法）造影剤は、造影剤としても知られ、体内の特定の組織や構造の可視性を高めるためにMRI検査中に使用される物質です。造影剤は、異なる組織間のコントラストを強くするために体内に導入され、特定部位の可視化を助け、MRIの診断精度を向上させる。
市場力学：
MRI造影剤市場は、精密な画像診断の需要、技術の進歩、画像診断を必要とする病状の増加などの要因により拡大しています。造影剤はMRI検査中に特定の組織の可視性を高め、正確な診断と治療計画の改善につながります。非侵襲的な画像診断に対する需要の高まりと、臨床ガイドラインに造影MRIが組み込まれたことが、市場成長の原動力となっています。技術革新は画質、安全性、患者予後の改善に寄与します。人口の高齢化と慢性疾患の罹患率の増加により、頻繁な画像診断が必要となり、造影剤の需要がさらに高まっています。現在進行中の研究では、安全性の懸念に対処し、患者の転帰を改善するため、より安全で効率的な薬剤の開発に重点が置かれています。ヘルスケアプロバイダーが正確な画像診断と患者中心の治療を優先する中、MRI検査における造影剤の利用は、特に医療インフラが成長しつつある新興市場で拡大する見通しです。
この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を対象としています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールはMRI造影剤の世界市場における各セグメントを包括的に評価することもできます。MRI造影剤業界の成長と動向は、この研究に全体的なアプローチを提供します。
地域分析：
本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカにおけるMRI造影剤市場の現在と将来の需要を強調する地域展望をカバーします。さらに、本レポートでは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。
カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。
目次
第1章 序文
第2章 エグゼクティブサマリー
- 市場のハイライト
- 世界市場スナップショット
第3章 MRI造影剤-産業分析
- イントロダクション：市場力学
- 市場促進要因
- 市場抑制要因
- 市場機会
- 業界動向
- ポーターのファイブフォース分析
- 市場魅力度分析
第4章 バリューチェーン分析
- バリューチェーン分析
- 原材料分析
- 原材料リスト
- 原材料メーカーリスト
- 主要原材料の価格動向
- 潜在的バイヤーのリスト
- マーケティングチャネル
- ダイレクトマーケティング
- インダイレクトマーケティング
- マーケティングチャネル発展動向
第5章 MRI造影剤の世界市場分析：製品別
- 製品別概要
- 実績データと予測データ
- 製品別分析
- 常磁性薬剤
- 超常磁性薬剤
第6章 MRI造影剤の世界市場分析：タイプ別
- タイプ別概要
- 実績データと予測データ
- タイプ別分析
- 臨床用
- 前臨床
第7章 MRI造影剤の世界市場分析：用途別
- 概要：用途別
- 実績データと予測データ
- 分析：用途別
- 消化器
- 静脈内
- 肝胆膵
- 神経イメージング
- その他
第8章 MRI造影剤の世界市場分析：最終用途別
- 最終用途別概要
- 実績データと予測データ
- 最終用途別分析
- 病院
- イメージングセンター
第9章 MRI造影剤の世界市場分析：地域別
- 地域別展望
- イントロダクション
- 北米売上分析
- 概要、実績と予測
- 北米：セグメント別
- 北米：国別
- 米国
- カナダ
- メキシコ
- 欧州売上分析
- 概要、実績と予測
- 欧州：セグメント別
- 欧州：国別
- 英国
- フランス
- ドイツ
- イタリア
- ロシア
- その他の欧州
- アジア太平洋売上分析
- 概要、実績と予測
- アジア太平洋：セグメント別
- アジア太平洋：国別
- 中国
- インド
- 日本
- 韓国
- オーストラリア
- 東南アジア
- その他のアジア太平洋
- ラテンアメリカ売上分析
- 概要、実績と予測
- ラテンアメリカ：セグメント別
- ラテンアメリカ：国別
- ブラジル
- アルゼンチン
- ペルー
- チリ
- その他のラテンアメリカ
- 中東・アフリカ売上分析
- 概要、実績と予測
- 中東・アフリカ：セグメント別
- 中東・アフリカ：国別
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他の中東とアフリカ
第10章 MRI造影剤企業の競合情勢
- MRI造影剤市場の競合
- 提携/協力/合意
- 合併・買収
- 新製品発売
- その他の開発
第11章 企業プロファイル
- 企業シェア分析
- 市場集中度
- GE Healthcare
- Bayer AG
- Guerbet GmbH
- Bracco Imaging Spa
- Vitalquan LLC
- Miltenyi Biotec B.V. & Co. Kg
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- Analysis by Product (USD MN)
- Paramagnetic Agents Market Sales by Geography (USD MN)
- Superparamagnetic Agents Market Sales by Geography (USD MN)
- Analysis Market by Type (USD MN)
- Clinical Market Sales by Geography (USD MN)
- Preclinical Market Sales by Geography (USD MN)
- Analysis by Application (USD MN)
- Gastrointestinal Market Sales by Geography (USD MN)
- Intravenous Market Sales by Geography (USD MN)
- Hepatobiliary Market Sales by Geography (USD MN)
- Neurological Imaging Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis by End-use (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Imaging Centers Market Sales by Geography (USD MN)
- Global Mri Contrast Media Agents Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Mri Contrast Media Agents Report
- Market Research Process
- Market Research Methodology
- Global Mri Contrast Media Agents Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Product
- Market Attractiveness Analysis by Type
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by End-use
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Product (USD MN)
- Paramagnetic Agents Market Sales by Geography (USD MN)
- Superparamagnetic Agents Market Sales by Geography (USD MN)
- Global Market Analysis by Type (USD MN)
- Clinical Market Sales by Geography (USD MN)
- Preclinical Market Sales by Geography (USD MN)
- Global Market Analysis by Application (USD MN)
- Gastrointestinal Market Sales by Geography (USD MN)
- Intravenous Market Sales by Geography (USD MN)
- Hepatobiliary Market Sales by Geography (USD MN)
- Neurological Imaging Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by End-use (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Imaging Centers Market Sales by Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
The global demand for MRI Contrast Media Agents Market is presumed to reach the market size of nearly USD 5.58 BN by 2030 from USD 2.98 BN in 2022 with a CAGR of 8.15% under the study period 2023 - 2030.
MRI (Magnetic Resonance Imaging) contrast media agents, also known as contrast agents, are substances used during MRI procedures to enhance the visibility of specific tissues and structures within the body. Contrast media agents are introduced into the body to create a stronger contrast between different tissues, aiding in the visualization of certain areas and improving the diagnostic accuracy of the MRI.
MARKET DYNAMICS:
The MRI Contrast Media Agents market is expanding due to factors such as the demand for precise diagnostic imaging, technological advancements, and the increasing prevalence of medical conditions requiring imaging. Contrast media agents enhance the visibility of specific tissues during MRI scans, leading to accurate diagnoses and improved treatment planning. The rising demand for non-invasive imaging procedures and the incorporation of contrast-enhanced MRI in clinical guidelines drive market growth. Technological innovations contribute to improved image quality, safety, and patient outcomes. The ageing population and the higher incidence of chronic diseases necessitate frequent imaging, further fueling the demand for contrast media agents. Ongoing research focuses on developing safer and more efficient agents to address safety concerns and improve patient outcomes. As healthcare providers prioritize accurate imaging and patient-centric care, the utilization of contrast media agents in MRI scans is poised to expand, particularly in emerging markets with growing healthcare infrastructure.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mri contrast media agents. The growth and trends of mri contrast media agents industry provide a holistic approach to this study.
MARKET SEGMENTATION:
This section of the mri contrast media agents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
- Paramagnetic Agents
- Superparamagnetic Agents
By Type
- Clinical
- Preclinical
By Application
- Gastrointestinal
- Intravenous
- Hepatobiliary
- Neurological Imaging
- Others
By End-Use
- Hospitals
- Imaging Centers
REGIONAL ANALYSIS:
This section covers the regional outlook, which accentuates current and future demand for the MRI Contrast Media Agents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the MRI Contrast Media Agents market include GE Healthcare, Bayer AG, Guerbet GmbH, Bracco Imaging Spa, Vitalquan, LLC, Miltenyi Biotec B.V. & Co. Kg. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . MRI CONTRAST MEDIA AGENTS - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY PRODUCT
- 5.1 Overview by Product
- 5.2 Historical and Forecast Data
- 5.3 Analysis by Product
- 5.4 Paramagnetic Agents Historic and Forecast Sales by Regions
- 5.5 Superparamagnetic Agents Historic and Forecast Sales by Regions
6 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY TYPE
- 6.1 Overview by Type
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Type
- 6.4 Clinical Historic and Forecast Sales by Regions
- 6.5 Preclinical Historic and Forecast Sales by Regions
7 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY APPLICATION
- 7.1 Overview by Application
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Application
- 7.4 Gastrointestinal Historic and Forecast Sales by Regions
- 7.5 Intravenous Historic and Forecast Sales by Regions
- 7.6 Hepatobiliary Historic and Forecast Sales by Regions
- 7.7 Neurological Imaging Historic and Forecast Sales by Regions
- 7.8 Others Historic and Forecast Sales by Regions
8 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY END-USE
- 8.1 Overview by End-use
- 8.2 Historical and Forecast Data
- 8.3 Analysis by End-use
- 8.4 Hospitals Historic and Forecast Sales by Regions
- 8.5 Imaging Centers Historic and Forecast Sales by Regions
9 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY GEOGRAPHY
- 9.1. Regional Outlook
- 9.2. Introduction
- 9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
- 9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
- 9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. South East Asia Sales Analysis
- 9.5.10. Rest Of Asia Pacific Sales Analysis
- 9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
- 9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis
10 . COMPETITIVE LANDSCAPE OF THE MRI CONTRAST MEDIA AGENTS COMPANIES
- 10.1. Mri Contrast Media Agents Market Competition
- 10.2. Partnership/Collaboration/Agreement
- 10.3. Merger And Acquisitions
- 10.4. New Product Launch
- 10.5. Other Developments
11 . COMPANY PROFILES OF MRI CONTRAST MEDIA AGENTS INDUSTRY
- 11.1. Company Share Analysis
- 11.2. Market Concentration Rate
- 11.3. GE Healthcare
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
- 11.4. Bayer AG
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
- 11.5. Guerbet GmbH
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
- 11.6. Bracco Imaging Spa
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
- 11.7. Vitalquan LLC
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
- 11.8. Miltenyi Biotec B.V. & Co. Kg
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
